Skip to content

Efficacy Evaluation of Quadruple Therapy Combined with Alysen Probiotic Blue Box for Helicobacter Pylori

Efficacy Evaluation of Quadruple Therapy Combined with Alysen Probiotic Blue Box for Helicobacter Pylori

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056446
Enrollment
Unknown
Registered
2022-02-06
Start date
2022-02-28
Completion date
Unknown
Last updated
2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric helicobacter pylori infection

Interventions

Experiment Group:Quadruple therapy for 2 weeks + Probiotic intervention for 28 days
Control Group:Quadruple therapy for 2 weeks + Placebo for 28 days

Sponsors

Xiangya School of Public Health, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 60 years; 2. No physical disability, genetic disease, mental system disease or major disease; 3. Positive for helicobacter pylori infection by C13 breath test; 4. Suitable for quadruple treatment; 5. Able to read and understand Chinese.

Exclusion criteria

Exclusion criteria: 1. Do not live locally; 2. Patients suffering from serious cardiovascular diseases, serious gastrointestinal diseases, serious liver and kidney diseases or endocrine diseases (such as colon cancer, severe enteritis, intestinal obstruction, combined with cardiovascular, liver and kidney hematopoietic diseases); 3. Those who have received surgical operations within the last six months; 4. Probiotics or prebiotics, antibiotics, bismuth preparation and laxatives were used in the past one month; 5. Women who are pregnant or breastfeeding; 6. People with lactose or fructose allergy; 7. Congenital lactose absorption disorder, congenital lactose enzyme deficiency crowd.

Design outcomes

Primary

MeasureTime frame
Helicobacter pylori eradication rate;Intestinal flora;Gastrointestinal Symptom Rating Scale (GSRS) score;Diarrhea and abdominal distension and other adverse reactions;Emotional state;

Countries

China

Contacts

Public ContactLin Qian

Xiangya School of Public Health, Central South University

linqian@csu.edu.cn+86 13874820173

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026